254 related articles for article (PubMed ID: 16412852)
21. Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).
Teirstein PS; Kao J; Watkins M; Tannenbaum MA; Laufer N; Chang M; Mehran R; Dangas G; Russell ME; Ellis SG; Stone GW
Am J Cardiol; 2005 Aug; 96(4):500-5. PubMed ID: 16098300
[TBL] [Abstract][Full Text] [Related]
22. Placental growth factor as short-term predicting biomarker in acute coronary syndrome patients with non-ST elevation myocardial infarction.
Marković M; Ignjatović S; Dajak M; Majkić-Singh N
South Med J; 2010 Oct; 103(10):982-7. PubMed ID: 20818309
[TBL] [Abstract][Full Text] [Related]
23. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
[TBL] [Abstract][Full Text] [Related]
24. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
[TBL] [Abstract][Full Text] [Related]
25. The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes.
Saenger AK; Jaffe AS
Med Clin North Am; 2007 Jul; 91(4):657-81; xi. PubMed ID: 17640541
[TBL] [Abstract][Full Text] [Related]
26. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial).
Nikolsky E; Grines CL; Cox DA; Garcia E; Tcheng JE; Sadeghi M; Mehran R; Lansky AJ; Na Y; Stone GW
Am J Cardiol; 2007 Apr; 99(8):1055-61. PubMed ID: 17437727
[TBL] [Abstract][Full Text] [Related]
27. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
Matsumoto T; Uemura S; Takeda Y; Matsui M; Okada S; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Onoue K; Kawata H; Kawakami R; Horii M; Saito Y
Intern Med; 2013; 52(10):1019-27. PubMed ID: 23676585
[TBL] [Abstract][Full Text] [Related]
28. Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I (PREDICT) Study.
Menown IB; Mathew TP; Gracey HM; Nesbitt GS; Murray P; Young IS; Adgey AA;
Am Heart J; 2003 Jun; 145(6):986-92. PubMed ID: 12796753
[TBL] [Abstract][Full Text] [Related]
29. Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study.
Campo G; Valgimigli M; Gemmati D; Percoco G; Tognazzo S; Cicchitelli G; Catozzi L; Malagutti P; Anselmi M; Vassanelli C; Scapoli G; Ferrari R
J Am Coll Cardiol; 2006 Dec; 48(11):2178-85. PubMed ID: 17161242
[TBL] [Abstract][Full Text] [Related]
30. Platelet function predicts myocardial damage in patients with acute myocardial infarction.
Frossard M; Fuchs I; Leitner JM; Hsieh K; Vlcek M; Losert H; Domanovits H; Schreiber W; Laggner AN; Jilma B
Circulation; 2004 Sep; 110(11):1392-7. PubMed ID: 15313953
[TBL] [Abstract][Full Text] [Related]
31. Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography.
Cavusoglu E; Ruwende C; Chopra V; Yanamadala S; Eng C; Pinsky DJ; Marmur JD
Coron Artery Dis; 2009 Mar; 20(2):112-7. PubMed ID: 19240644
[TBL] [Abstract][Full Text] [Related]
32. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
[TBL] [Abstract][Full Text] [Related]
33. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
[TBL] [Abstract][Full Text] [Related]
34. Effects of tirofiban plus clopidogrel versus clopidogrel plus provisional abciximab on biomarkers of myocardial necrosis in patients with non-ST-elevation acute coronary syndromes treated with early aggressive approach. Results of the CLOpidogrel, upstream TIrofiban, in cath Lab Downstream Abciximab (CLOTILDA) study.
Leoncini M; Toso A; Maioli M; Bellandi F; Badia T; Politi A; De Servi S; Dabizzi RP
Am Heart J; 2005 Sep; 150(3):401. PubMed ID: 16169315
[TBL] [Abstract][Full Text] [Related]
35. Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists.
Mark B; Schneider S; Schiele R; Taubert G; Kilkowski C; Seidl K; Nagel D; Seiler D; Senges J; Zahn R
Z Kardiol; 2003 Dec; 92(12):1018-24. PubMed ID: 14663612
[TBL] [Abstract][Full Text] [Related]
36. Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial.
Bui AH; Bonaca MP; Sabatine MS; Ray KK; Rifai N; Cannon CP; Morrow DA
J Thromb Thrombolysis; 2012 Aug; 34(2):222-8. PubMed ID: 22446996
[TBL] [Abstract][Full Text] [Related]
37. Selection of glycoprotein IIb/IIIa inhibitors for upstream use in patients with diabetes experiencing unstable angina or non-ST segment elevation myocardial infarction. What have we learned in the last 10 years?
Silva MA; Gandhi PJ
J Clin Pharm Ther; 2004 Dec; 29(6):497-510. PubMed ID: 15584937
[TBL] [Abstract][Full Text] [Related]
38. [Platelet glycoprotein IIB-IIIA receptor inhibitors in patients with ischemic heart disease].
Patti G; Fossati C; Manzoli A; D'Ambrosio A; Abbate A; Montesanti R; Di Sciascio G
Clin Ter; 2000; 151(4):301-6. PubMed ID: 11107681
[TBL] [Abstract][Full Text] [Related]
39. Placental growth factor and B-type natriuretic peptide as independent predictors of risk from a multibiomarker panel in suspected acute coronary syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers [ARROW]) study.
Glaser R; Peacock WF; Wu AH; Muller R; Möckel M; Apple FS
Am J Cardiol; 2011 Mar; 107(6):821-6. PubMed ID: 21247525
[TBL] [Abstract][Full Text] [Related]
40. Clinical predictors of 30-day cardiac events in patients with acute coronary syndrome at a community hospital.
Tadros GM; McConnell TR; Wood GC; Costello JM; Iliadis EA
South Med J; 2003 Nov; 96(11):1113-20. PubMed ID: 14632360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
